梅毒検査市場：タイプ別、検査場所別、地域別、2025-2033年

梅毒検査市場の世界市場規模は2024年に13億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに20億米ドルに達し、2025年から2033年にかけて4.9％の成長率（CAGR）を示すと予測しています。性感染症（STDs）の蔓延、流産の増加、ヘルスケア分野における効果的な疾病診断・検査ソリューションに対するニーズの高まりが、市場を牽引する主な要因のひとつです。

梅毒は性感染症（STI）の一つで、通常性的接触によって引き起こされ、皮膚や粘膜の接触を通じて個人間で感染します。性器や口の直腸に痛みのないただれとして始まる。治療せずに放置すると、脳、神経、血管、関節を損傷する三次梅毒の合併症を引き起こす可能性があります。現在では、迅速血漿反応検査（RPR）と性病検査（VDRL）が標準的な検査法として開業医に用いられています。これらのアプローチは、より良い治療のための早期発見を提供し、性感染症（STDs）の蔓延と開発を緩和します。その結果、梅毒検査は、梅毒のタイプを診断し、適切な治療を特定するために、検査室やポイントオブケア（PoC）センターで頻繁に使用されています。

梅毒検査市場傾向：

STD治療に対する意識の高まりは、市場成長を促進する重要な要因の一つです。これに伴い、さまざまな国の政府、非政府組織（NGO）が梅毒を含む性病の予防や利用可能な治療法について一般大衆を啓発するキャンペーンを積極的に実施しています。その結果、梅毒迅速検査キットなどの梅毒検査キットの普及が促進され、市場の成長を後押ししています。これらのキットは、効果的な診断結果を伴う在宅検査を提供するため、タイムリーな意思決定が可能であり、これも市場成長に寄与しています。さらに、これらの検査キットはオンライン小売店や店舗内の薬局で手頃な価格帯で入手できるため、使用の利便性が高く、市場成長に寄与しています。これとは別に、ヘルスケア部門の大幅な改善と、効果的な治療代替品を発売するための最近の研究開発（R&D）活動は、市場成長にプラスの影響を与えています。さらに、性感染症の検査に有利な医療償還政策が存在することも、市場成長に寄与しています。梅毒を含む性病の有病率の増加、無防備な性交渉の増加、効果的なスクリーニングプログラムの広範な実施、疾患の早期診断への重点的な取り組み強化などのその他の要因が、市場に明るい見通しを生み出しています。

本レポートで扱う主な質問

• 世界の梅毒検査市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
• 梅毒検査市場の世界市場における促進要因、抑制要因、機会は何か？
• 主要な地域市場とは？
• 最も魅力的な梅毒検査市場はどの国か？
• タイプ別の市場内訳は？
• 検査場所別の市場内訳は？
• 世界の梅毒検査市場の競合構造は？
• 世界の梅毒検査市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の梅毒検査市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：タイプ別

• 一次梅毒と二次梅毒
  • 市場動向
  • 市場予測
• 潜伏梅毒と三次梅毒
  • 市場動向
  • 市場予測

第7章 市場内訳：検査場所別

• 臨床検査
  • 市場動向
  • 市場予測
• POC検査
  • 市場動向
  • 市場予測

第8章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ

第9章 促進要因・抑制要因・機会

• 概要
• 促進要因
• 抑制要因
• 機会

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第12章 価格分析

第13章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Abbott Laboratories
  • Becton Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • DRG International Inc.（BioCheck Inc.）
  • F. Hoffmann-La Roche AG
  • Siemens Healthineers AG（Siemens AG）
  • Thermo Fisher Scientific Inc.

List of Figures

• Figure 1: Global: Syphilis Testing Market: Major Drivers and Challenges
• Figure 2: Global: Syphilis Testing Market: Sales Value (in Billion USD), 2019-2024
• Figure 3: Global: Syphilis Testing Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 4: Global: Syphilis Testing Market: Breakup by Type (in %), 2024
• Figure 5: Global: Syphilis Testing Market: Breakup by Location of Testing (in %), 2024
• Figure 6: Global: Syphilis Testing Market: Breakup by Region (in %), 2024
• Figure 7: Global: Syphilis Testing (Primary and Secondary Syphilis) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 8: Global: Syphilis Testing (Primary and Secondary Syphilis) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 9: Global: Syphilis Testing (Latent and Tertiary Syphilis) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 10: Global: Syphilis Testing (Latent and Tertiary Syphilis) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 11: Global: Syphilis Testing (Laboratory Testing) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 12: Global: Syphilis Testing (Laboratory Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 13: Global: Syphilis Testing (Point-of-Care (POC) Testing) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 14: Global: Syphilis Testing (Point-of-Care (POC) Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 15: North America: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 16: North America: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 17: United States: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 18: United States: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 19: Canada: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 20: Canada: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 21: Asia-Pacific: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 22: Asia-Pacific: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 23: China: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 24: China: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 25: Japan: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 26: Japan: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 27: India: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 28: India: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 29: South Korea: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 30: South Korea: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 31: Australia: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 32: Australia: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 33: Indonesia: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 34: Indonesia: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 35: Others: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 36: Others: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 37: Europe: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 38: Europe: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 39: Germany: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 40: Germany: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 41: France: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 42: France: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 43: United Kingdom: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 44: United Kingdom: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 45: Italy: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 46: Italy: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 47: Spain: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 48: Spain: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 49: Russia: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 50: Russia: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 51: Others: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 52: Others: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 53: Latin America: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 54: Latin America: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 55: Brazil: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 56: Brazil: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 57: Mexico: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 58: Mexico: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 59: Others: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 60: Others: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 61: Middle East and Africa: Syphilis Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 62: Middle East and Africa: Syphilis Testing Market: Breakup by Country (in %), 2024
• Figure 63: Middle East and Africa: Syphilis Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 64: Global: Syphilis Testing Industry: Drivers, Restraints, and Opportunities
• Figure 65: Global: Syphilis Testing Industry: Value Chain Analysis
• Figure 66: Global: Syphilis Testing Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Syphilis Testing Market: Key Industry Highlights, 2024 & 2033
• Table 2: Global: Syphilis Testing Market Forecast: Breakup by Type (in Million USD), 2025-2033
• Table 3: Global: Syphilis Testing Market Forecast: Breakup by Location of Testing (in Million USD), 2025-2033
• Table 4: Global: Syphilis Testing Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 5: Global: Syphilis Testing Market: Competitive Structure
• Table 6: Global: Syphilis Testing Market: Key Players

The global syphilis testing market size reached USD 1.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.0 Billion by 2033, exhibiting a growth rate (CAGR) of 4.9% during 2025-2033. The growing prevalence of sexually transmitted diseases (STDs), the increasing incidences of miscarriages, and the rising need for effective disease diagnosing and testing solutions in the healthcare sector represent some of the key factors driving the market.

Syphilis refers to a sexually transmitted infection (STI) that is usually caused by sexual contact and is spread amongst individuals through the skin or mucous membrane contact. It starts as a painless sore on the genitals and rectum of the mouth. If left untreated, it might trigger complications of tertiary syphilis, wherein the disease may damage the brain, nerves, blood vessels, and joints. At present, rapid plasma reagin (RPR) and venereal diseases research laboratory (VDRL) are standard testing practices that are being used by practitioners. These approaches provide early detection for better treatment and mitigate the spread and development of sexually transmitted diseases (STDs). As a result, syphilis testing is frequently used in laboratories and point-of-care (PoC) centers to diagnose the syphilis type and identify its proper treatment.

Syphilis Testing Market Trends:

The increasing awareness regarding STD treatment represents one of the key factors driving the market growth. In line with this, governments of various nations, along with different non-governmental organizations (NGOs) are actively undertaking campaigns to sensitize the common mass regarding the prevention of STDs, including syphilis, and the available treatment options. This, in turn, is facilitating the adoption of syphilis testing kits, such as syphilis rapid test strips, which is favorably supporting the market growth. These kits offer at-home testing with effective diagnostic results, and thus timely decision-making, which is also contributing to the market growth. Additionally, the convenience of usage and the easy availability of these test kits at online retail stores and in-store pharmacies at affordable price points are contributing to the market growth. Apart from this, the considerable improvements in the healthcare sector and the recent research and development (R&D) activities to launch effective treatment alternatives are positively impacting the market growth. Moreover, the presence of favorable medical reimbursement policies for the testing of sexually transmitted infections is contributing to the market growth. Other factors, such as the increasing prevalence of STDs, including syphilis, rising incidences of unprotected sexual intercourse, the widespread implementation of effective screening programs, and an enhanced focus on the early diagnostic of the disease, are creating a positive outlook for the market.

Key Market Segmentation:

Type Insights:

• Primary and Secondary Syphilis
• Latent and Tertiary Syphilis
• The report has also provided a detailed breakup and analysis of the syphilis testing market based on the type. This includes primary and secondary, and latent and tertiary syphilis. According to the report, primary and secondary syphilis represented the largest segment.

Location of Testing Insights:

• Laboratory Testing
• Point-of-Care (POC) Testing

Regional Insights:

• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for syphilis testing. Some of the factors driving the North America syphilis testing market included the increasing prevalence of STDs, significant technological advancements, and extensive research and development (R&D) activities.

Competitive Landscape:

• The report has also provided a comprehensive analysis of the competitive landscape in the global syphilis testing market. Detailed profiles of all major companies have also been provided. Some of the companies covered includes Abbott Laboratories, Becton Dickinson and Company, Bio-Rad Laboratories Inc., Danaher Corporation, DRG International Inc. (BioCheck Inc.), F. Hoffmann-La Roche AG, Siemens Healthineers AG (Siemens AG), Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

• How has the global syphilis testing market performed so far and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global syphilis testing market?
• What are the key regional markets?
• Which countries represent the most attractive syphilis testing markets?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the location of testing?
• What is the competitive structure of the global syphilis testing market?
• Who are the key players/companies in the global syphilis testing market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Syphilis Testing Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Primary and Secondary Syphilis
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Latent and Tertiary Syphilis
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Location of Testing

• 7.1 Laboratory Testing
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Point-of-Care (POC) Testing
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

• 9.1 Overview
• 9.2 Drivers
• 9.3 Restraints
• 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Abbott Laboratories
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
    • 13.3.1.3 Financials
    • 13.3.1.4 SWOT Analysis
  • 13.3.2 Becton Dickinson and Company
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
    • 13.3.2.3 Financials
    • 13.3.2.4 SWOT Analysis
  • 13.3.3 Bio-Rad Laboratories Inc.
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
    • 13.3.3.3 Financials
    • 13.3.3.4 SWOT Analysis
  • 13.3.4 Danaher Corporation
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 Financials
    • 13.3.4.4 SWOT Analysis
  • 13.3.5 DRG International Inc. (BioCheck Inc.)
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
  • 13.3.6 F. Hoffmann-La Roche AG
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 Financials
  • 13.3.7 Siemens Healthineers AG (Siemens AG)
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
    • 13.3.7.3 Financials
    • 13.3.7.4 SWOT Analysis
  • 13.3.8 Thermo Fisher Scientific Inc.
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
    • 13.3.8.3 Financials
    • 13.3.8.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.